2018
DOI: 10.1155/2018/7931849
|View full text |Cite
|
Sign up to set email alerts
|

Ozone Therapy as Adjuvant for Cancer Treatment: Is Further Research Warranted?

Abstract: Introduction This article provides an overview of the potential use of ozone as an adjuvant during cancer treatment. Methods We summarize the findings of the most relevant publications focused on this goal, and we include our related clinical experience. Results Over several decades, prestigious journals have published in vitro studies on the capacity of ozone to induce direct damage on tumor cells and, as well, to enhance the effects of radiotherapy and chemotherapy. Indirect effects have been demonstrated in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
34
0
11

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
4

Relationship

2
6

Authors

Journals

citations
Cited by 50 publications
(48 citation statements)
references
References 67 publications
0
34
0
11
Order By: Relevance
“…There is a rational support for a potential enhancing effect of the "chemotherapy + ozone" combination as we have described in a recent review, which merits further research [87]. However, this potential and controversial combination during cancer treatment should not be hugely relevant for patients in the following situations:…”
Section: Discussion and Prospectsmentioning
confidence: 93%
“…There is a rational support for a potential enhancing effect of the "chemotherapy + ozone" combination as we have described in a recent review, which merits further research [87]. However, this potential and controversial combination during cancer treatment should not be hugely relevant for patients in the following situations:…”
Section: Discussion and Prospectsmentioning
confidence: 93%
“…Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough, malaise and dry cough at the prodromal phase [5]. Bilateral lung involvement with ground-glass opacity was the most common finding from computed clinical evidence to support the potential role of OT in the prevention and management of cytotoxicity induced by different drugs and diseases including viral diseases [21][22][23][24]. The main mechanism is related to the modulation of the oxidative stress and pro-inflammatory cytokines.…”
Section: Introductionmentioning
confidence: 88%
“…These byproducts of the reaction act as secondary messengers and induce a further adaptive hormetic responses [56][57][58]. Ozone at a therapeutic dose "only acts" as a modulator or pro-drug and, by inducing secondary messengers, will enhance subsequent adaptive responses [21].…”
Section: Ozone Therapy As Redox Modulatormentioning
confidence: 99%
See 1 more Smart Citation
“…In autohemotherapy, small amount of blood is collected from the patient, then exposed ex vivo to ozone then infused back into the patient (Smith et al, 2017). Because ozone is a potent oxidant and a highly reactive molecule, it has strong bactericidal, antiviral, anti-fungal and antiprotozoalactions (Duricic et al, 2015;Yamayoshi and Tatsumi, 1993;Sugita et al, 1992;Sato et al, 1990) as well as other therapeutic effects (Duricic et al, 2015;Yamayoshi and Tatsumi, 1993;Sugita et al, 1992;Sato et al, 1990;Clavo et al, 2018;Kashiwagi et al, 2001). Due to the advantage of its multifaceted route of administration, ozone has been used to treat several pathologies such as cancers (Clavo et al, 2018;Dogan et al, 2018), bad abscesses (Karatieieva et al, 2017;Li et al, 2018) and chronic wounds (Fitzpatrick et al, 2018), skin diseases[such as acne (Gloor and Lipphardt, 1976), eczema (Kosheleva and Kulikov, 2001) and psoriasis (Evstigneeva et al, 2018), HIV infection (Garber et al, 1991;Carpendale et al, 1993;Frankum and Katelaris, 1993;OPOI, 1994), fibromyalgia (Hidalgo-Tallon et al, 2013), asthma (Turner et al, 1989), inflammatory conditions (Kucukgul et al, 2016) including arthritis (Raeissadat et al, 2018;Manoto et al, 2018), cardiac conditions (Buyuklu et al, 2017), liver disorders (Safwat et al, 2014;Tezcan et al, 2018), eye disorders (Kaya et al, 2017), urinary tract pathologies (Tasdemir et al, 2013), dyslipidemia…”
Section: Introductionmentioning
confidence: 99%